Gastroenterology (all articles)
SR | Fecal transplantation for treatment of inflammatory bowel disease
2 May, 2023 | 13:39h | UTCFecal transplantation for treatment of inflammatory bowel disease – Cochrane Library
Review | Helicobacter pylori infection
2 May, 2023 | 13:37h | UTCHelicobacter pylori infection – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Commentary on Twitter
A Primer published by @DiseasePrimers summarizes the epidemiology, pathophysiology, diagnosis and management of Helicobacter pylori infection, and discusses patient quality of life and open research questions. https://t.co/WawWpSGBU9 pic.twitter.com/ghFTbyp0ln
— Nature Portfolio (@NaturePortfolio) April 24, 2023
RCT | Molecular point-of-care testing for gastroenteritis reduced isolation time but increased antibiotic use
28 Apr, 2023 | 13:15h | UTC
RCT | Anti-TNF in combination with low dose methotrexate vs anti-TNF monotherapy in pediatric Crohn’s disease
26 Apr, 2023 | 13:55h | UTCComparative Effectiveness of Anti-TNF in Combination with Low Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn’s Disease: a Pragmatic Randomized Trial – Gastroenterology (link to abstract – $ for full-text)
AGA Practical Guidance | Diagnosis and management of extraesophageal gastroesophageal reflux disease
25 Apr, 2023 | 14:50h | UTCCommentary: Guidance offered on management of extraesophageal GERD – ACP Gastroenterology
Commentary on Twitter (thread – click for more)
https://twitter.com/joanwchen/status/1648804839600668675
Review | New treatment paradigms in primary biliary cholangitis
26 Apr, 2023 | 13:49h | UTCNew Treatment Paradigms in Primary Biliary Cholangitis – Clinical Gastroenterology and Hepatology
Perspective | Liver transplantation for patients with severe acute on chronic liver failure: it is time to change paradigms
25 Apr, 2023 | 14:37h | UTC
Commentary on Twitter
Liver #Tx in severe acute on chronic failure
➡️ #ICU care crucial in ACLF-3
➡️ improve referrals to LT centers & pre-LT workup
➡️ to decide to put pt on waitlist consider donor shortage/collective utility of LT
➡️ identifying transplantability window
🖇️ https://t.co/VZxDyZ1k74 pic.twitter.com/6YOcd5rzMu— Intensive Care Medicine (@yourICM) April 19, 2023
Brief Review | Diagnosis and management of neuroendocrine tumors
25 Apr, 2023 | 14:16h | UTCDiagnosis and management of neuroendocrine tumours – Clinical Medicine Journal
RCT | Bariatric–metabolic surgery is more effective than lifestyle intervention plus best medical care in non-alcoholic steatohepatitis
24 Apr, 2023 | 14:03h | UTCNews Release: Surgery most effective treatment of metabolic liver disease – King’s College London
Commentary on Twitter
New @TheLancet – Verrastro et al – Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trialhttps://t.co/pCWahvbReQ#NASH #NAFLD #fattyliver #livertwitter pic.twitter.com/xNMsAskJF9
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) April 21, 2023
SR | Etiology, diagnosis, and modern management of chronic pancreatitis
24 Apr, 2023 | 13:29h | UTCEtiology, Diagnosis, and Modern Management of Chronic Pancreatitis: A Systematic Review – JAMA Surgery (free for a limited period)
M-A | Adverse events related to tirzepatide (a dual GIP/GLP-1 receptor agonist)
21 Apr, 2023 | 12:59h | UTCAdverse Events Related to Tirzepatide – Journal of the Endocrine Society
Related:
Tirzepatide Once Weekly for the Treatment of Obesity – New England Journal of Medicine
Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis – Nature Medicine
Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial – The Lancet (link to abstract – $ for full-text)
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial – The Lancet (link to abstract – $ for full-text)
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial – The Lancet (link to abstract – $ for full-text)
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
Guideline | Management of psychiatric disorders in patients with hepatic and gastrointestinal diseases
19 Apr, 2023 | 13:07h | UTC
Guideline | Intrahepatic cholestasis of pregnancy
18 Apr, 2023 | 13:24h | UTCIntrahepatic cholestasis of pregnancy – BJOG
Brief Review | Chronic cough and inflammatory bowel disease: an under-recognized association?
18 Apr, 2023 | 13:07h | UTCChronic cough and inflammatory bowel disease: an under-recognised association? – Breathe
Commentary on Twitter
Breathe: Respiratory complications of inflammatory bowel disease (IBD) are common and may be under-recognised. Chronic cough may present many years after a colectomy for IBD, is typically productive and can be very responsive to inhaled corticosteroids. https://t.co/9hw3bvMeGp pic.twitter.com/ZJURzidpMU
— ERS publications (@ERSpublications) April 15, 2023
Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU
17 Apr, 2023 | 13:19h | UTCGuidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Neurology, Peri-Transplant Medicine, Infectious Disease, and Gastroenterology Considerations – Critical Care Medicine (free for a limited period)
Executive Summary: Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Neurology, Peri-Transplant Medicine, Infectious Disease, and Gastroenterology Considerations – Critical Care Medicine (free for a limited period)
Review | Diagnostic, structured classification and therapeutic approach in cystic pancreatic lesions
12 Apr, 2023 | 12:58h | UTCRelated:
Cystic pancreatic lesions: MR imaging findings and management.
Recommendations for the management of incidental pancreatic findings in adults.
Pancreatic cystic neoplasms: a review of current recommendations for surveillance and management
Management of Pancreatic Cystic Lesions
Consensus Recommendations: Diagnosis and Surveillance of Incidental Pancreatic Cystic Lesions
Review: Pancreatic Cystic Lesions
Guidelines on pancreatic cystic neoplasms
Screening colonoscopy in seniors: common in patients with limited life expectancy and associated with higher complication risks
11 Apr, 2023 | 14:30h | UTCFrequency of Use and Outcomes of Colonoscopy in Individuals Older Than 75 Years – JAMA Internal Medicine (link to abstract – $ for full-text)
Related: Study reveals overuse of surveillance colonoscopy in older adults with limited life expectancy
Commentary:
In older adults >75 years of age, most screening colonoscopies were in patients in patients with limited life expectancy (defined as <10 years) and associated with increased risk of adverse events. https://t.co/XOsy2UKNRx @Jessica_Halabi @MRothbergMD @burkegastrodoc
— JAMA Internal Medicine (@JAMAInternalMed) April 4, 2023
M-A | Irritable bowel syndrome is not associated with an increased risk of polyps and colorectal cancer
11 Apr, 2023 | 14:19h | UTC
Review | Anticoagulation in patients with liver cirrhosis: friend or foe?
11 Apr, 2023 | 14:17h | UTCAnticoagulation in Patients with Liver Cirrhosis: Friend or Foe? – Digestive Diseases and Sciences
Review | Assessing the risk of surgery in patients with cirrhosis
10 Apr, 2023 | 13:20h | UTCAssessing the risk of surgery in patients with cirrhosis – Hepatology Communications
Global epidemiology of cirrhosis — Etiology, trends and predictions
6 Apr, 2023 | 13:27h | UTC
Commentary on Twitter
New content online: Global epidemiology of cirrhosis — aetiology, trends and predictions https://t.co/EbgDWTjOyI pic.twitter.com/Cj7KFoWtLi
— Nature Reviews Gastroenterology & Hepatology (@NatRevGastroHep) March 28, 2023
RCT | Etrasimod outperforms placebo in ulcerative colitis induction & maintenance
6 Apr, 2023 | 12:56h | UTC
Commentary on Twitter
Just published @TheLancet – Sandborn et al – Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies https://t.co/BVDWtESWLP#gitwitter #ibd #ulcerativecolitis #ECCO23 #ECCO2023 pic.twitter.com/hjyJ0tdtWd
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) March 3, 2023
Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019
5 Apr, 2023 | 13:27h | UTC
Two FITs better than one: enhancing diagnostic performance for colorectal cancer in symptomatic populations
4 Apr, 2023 | 13:32h | UTC
Brief Review | What every gastroenterologist should know about gastrointestinal neuroendocrine tumors
4 Apr, 2023 | 13:29h | UTC